922 related articles for article (PubMed ID: 30403550)
1. Clinical Application and Potential of Fecal Microbiota Transplantation.
Ooijevaar RE; Terveer EM; Verspaget HW; Kuijper EJ; Keller JJ
Annu Rev Med; 2019 Jan; 70():335-351. PubMed ID: 30403550
[TBL] [Abstract][Full Text] [Related]
2. Fecal microbiota transplantation - methods of treatment of recurrent Clostridium difficile infections and other diseases.
Juszczuk K; Grudlewska K; Mikucka A; Gospodarek E
Postepy Hig Med Dosw (Online); 2017 Mar; 71(0):220-226. PubMed ID: 28345530
[TBL] [Abstract][Full Text] [Related]
3. [Faecal microbiota transplantation for the treatment of bowel disease].
Rode AA; Chehri M; Petersen AM; Bytzer P
Ugeskr Laeger; 2017 Jul; 179(31):. PubMed ID: 28869008
[TBL] [Abstract][Full Text] [Related]
4. Any Future for Fecal Microbiota Transplantation as Treatment Strategy for Inflammatory Bowel Diseases?
Kump P; Högenauer C
Dig Dis; 2016; 34 Suppl 1():74-81. PubMed ID: 27548724
[TBL] [Abstract][Full Text] [Related]
5. Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: an update.
Holleran G; Scaldaferri F; Ianiro G; Lopetuso L; Mc Namara D; Mele MC; Gasbarrini A; Cammarota G
Drugs Today (Barc); 2018 Feb; 54(2):123-136. PubMed ID: 29637938
[TBL] [Abstract][Full Text] [Related]
6. Fecal microbiota transplantation: past, present and future perspectives.
Bibbò S; Ianiro G; Gasbarrini A; Cammarota G
Minerva Gastroenterol Dietol; 2017 Dec; 63(4):420-430. PubMed ID: 28927251
[TBL] [Abstract][Full Text] [Related]
7. Fecal microbiota transplantation for irritable bowel syndrome: Current evidence and perspectives.
Dai C; Huang YH; Jiang M
World J Gastroenterol; 2024 Apr; 30(16):2179-2183. PubMed ID: 38690018
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory Bowel Disease Affects the Outcome of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.
Khoruts A; Rank KM; Newman KM; Viskocil K; Vaughn BP; Hamilton MJ; Sadowsky MJ
Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1433-8. PubMed ID: 26905904
[TBL] [Abstract][Full Text] [Related]
9. Are There Potential Applications of Fecal Microbiota Transplantation beyond Intestinal Disorders?
Zhou Y; Xu H; Huang H; Li Y; Chen H; He J; Du Y; Chen Y; Zhou Y; Nie Y
Biomed Res Int; 2019; 2019():3469754. PubMed ID: 31467881
[TBL] [Abstract][Full Text] [Related]
10. Fecal microbiota transplantation as a new therapy: from Clostridioides difficile infection to inflammatory bowel disease, irritable bowel syndrome, and colon cancer.
Borody TJ; Eslick GD; Clancy RL
Curr Opin Pharmacol; 2019 Dec; 49():43-51. PubMed ID: 31173991
[TBL] [Abstract][Full Text] [Related]
11. Fecal microbiota transplantation for the treatment of Clostridium difficile infection.
Rao K; Safdar N
J Hosp Med; 2016 Jan; 11(1):56-61. PubMed ID: 26344412
[TBL] [Abstract][Full Text] [Related]
12. Microbiome changes associated with sustained eradication of Clostridium difficile after single faecal microbiota transplantation in children with and without inflammatory bowel disease.
Hourigan SK; Chen LA; Grigoryan Z; Laroche G; Weidner M; Sears CL; Oliva-Hemker M
Aliment Pharmacol Ther; 2015 Sep; 42(6):741-52. PubMed ID: 26198180
[TBL] [Abstract][Full Text] [Related]
13. Fecal microbiota transplantation for recurrent Clostridioides difficile infection.
Haber SL; Raney CRK; Larson TL; Lau JP
Am J Health Syst Pharm; 2019 Jun; 76(13):935-942. PubMed ID: 31361890
[TBL] [Abstract][Full Text] [Related]
14. Fecal microbiota transplantation beyond Clostridioides difficile infections.
Wortelboer K; Nieuwdorp M; Herrema H
EBioMedicine; 2019 Jun; 44():716-729. PubMed ID: 31201141
[TBL] [Abstract][Full Text] [Related]
15. Systematic review with meta-analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome.
Ianiro G; Eusebi LH; Black CJ; Gasbarrini A; Cammarota G; Ford AC
Aliment Pharmacol Ther; 2019 Aug; 50(3):240-248. PubMed ID: 31136009
[TBL] [Abstract][Full Text] [Related]
16. Application and development of fecal microbiota transplantation in the treatment of gastrointestinal and metabolic diseases: A review.
Mahmoudi H; Hossainpour H
Saudi J Gastroenterol; 2023; 29(1):3-11. PubMed ID: 36412458
[TBL] [Abstract][Full Text] [Related]
17. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
[TBL] [Abstract][Full Text] [Related]
18. Fecal Microbiota Transplantation for the Management of
Paknikar R; Pekow J
Surg Infect (Larchmt); 2018; 19(8):785-791. PubMed ID: 30300561
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors for Gastrointestinal Symptoms Following Successful Eradication of Clostridium difficile by Fecal Microbiota Transplantation (FMT).
Allegretti JR; Kassam Z; Fischer M; Kelly C; Chan WW
J Clin Gastroenterol; 2019 Oct; 53(9):e405-e408. PubMed ID: 30882536
[TBL] [Abstract][Full Text] [Related]
20. Successful therapy of Clostridium difficile infection with fecal microbiota transplantation.
Konturek PC; Koziel J; Dieterich W; Haziri D; Wirtz S; Glowczyk I; Konturek K; Neurath MF; Zopf Y
J Physiol Pharmacol; 2016 Dec; 67(6):859-866. PubMed ID: 28195066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
